Displaying 25 - 36 of 54
Immune-Mediated and Cholestatic Diseases

Genetic variants associated with cholestasis in adult clinical practice

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Questions and answers

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Demonstrating clinical outcomes through real- world data

Webcasts
View
Immune-Mediated and Cholestatic Diseases

AdvanzPharma: Shifting Paradigms in PBC Management (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

GSK: "Investigating IBAT inhibition in itch – a new tool for an age-old problem?" (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

GSK: "Practical tips towards providing holistic care to patients with PBC" (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Albireo Pharma, an Ipsen Company: “New Horizons in cholestatic liver disease” (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Ipsen: "Scratching beyond the surface in PBC: From current unmet medical needs to future prospects" (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Mirum Pharmaceuticals, Inc: "Meet the Experts in Cholestatic Liver Disease" (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

What is the unmet burden of itch from an HCP perspective?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

How can we face itch in the present?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

What is the unmet burden of itch from a patient perspective?

Webcasts
View
Displaying 25 - 36 of 54